Why Amneal

Amneal Biosciences

We deliver value

Amneal Biosciences* is innovating access to essential medicines by building on Amneal’s established legacy.

Numbers
Infographic Infographic
Infographic Infographic
Infographic Infographic
Infographic Infographic
Infographic Infographic

Exceptional quality.
Unwavering commitment.
Life-changing care.
That’s the Amneal way.

*Amneal Biosciences is a division within Amneal’s Generics segment, which is a part of Amneal Pharmaceuticals LLC.

†Amneal’s generic savings in the United States in 2022 was calculated by taking the total national savings estimated by the Association for Accessible Medicines and determining Amneal’s market share by volume, data of which was derived from IQVIA.

Curious about our portfolio, patient support, or what makes us unique?

Image, scientific rendering of a biosimilar.

Innovative
medicines

Pharmacy directors: our portfolio offers affordable options for your patients.

Explore
Image, hands holding.

Meaningful
support

Our access and affordability support helps patients and providers navigate the treatment journey.

Learn
Image, photo of a customer service support representative.

Tailored
solutions

We customize solutions for your unique needs.

Discover
Image, photo of Chirag Patel, Co-Founder and Co-Chief Executive Officer of Amneal Pharmaceuticals. Image, photo of Chirag Patel, Co-Founder and Co-Chief Executive Officer of Amneal Pharmaceuticals.
“

We believe people need
affordable medicine, so
we are here.

— Chirag Patel

Co-Founder & Co-Chief Executive Officer of Amneal Pharmaceuticals

Image, photo of Courtney Koster, Senior Director of National Corporate Accounts. Image, photo of Courtney Koster, Senior Director of National Corporate Accounts.
“

By adapting to ever-shifting market dynamics, Amneal is quickly becoming a leading provider of high-quality and affordable sophisticated medications.

— Courtney Koster

Sr. Director, National Corporate Accounts

Image, photo of Sean McGowan, Senior Vice President, Biosimilars and Branded Oncology. Image, photo of Sean McGowan, Senior Vice President, Biosimilars and Branded Oncology.
“

Our PATHways program is supporting access to therapies and providing co-pay assistance to qualified patients.

— Sean McGowan

Senior Vice President, Biosimilars and Branded Oncology

Please reach out if you have questions or want to learn how we can help address organizational challenges.

Connect with us

The content on this site is intended for pharmacy directors and healthcare professionals. Educational information for your patients around access and support is available in the Access & Patient Support and Resources sections of this website.

About Amneal Biosciences

This site uses cookies to analyze traffic as described in our Privacy Policy.
Please click the “Accept” button or continue to use our site if you agree to our use of cookies.

Accept